Rhythm and song: Breath management in Idiopathic Interstitial Pneumonias (IIP's). Pilot study.

A. Russell (London, United Kingdom)

Source: International Congress 2017 – Implementation of respiratory physiotherapy interventions in clinical practice
Session: Implementation of respiratory physiotherapy interventions in clinical practice
Session type: Thematic Poster
Number: 2536

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Russell (London, United Kingdom). Rhythm and song: Breath management in Idiopathic Interstitial Pneumonias (IIP's). Pilot study.. 2536

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Unclassifiable Interstitial Lung Disease (ILD). Why?
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Evaluation of Dyspnea Questionnaires in Patients with Idiopathic Pulmonary Fibrosis (IPF).
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018

Value of community based Pulmonary Rehabilitation (PR) for patients with Interstitial Lung Disease (ILD): A retrospective review
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019


Comparison of Eosinophilic and Non-eosinophilic Cases with Chronic Obstructive Pulmonary Disease (COPD) in terms of Clinical Arrival, Exacerbations, Quality of Life and Response to Treatment: A Prospective Study
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019

LATE-BREAKING ABSTRACT: Efficacy of Pirfenidone for Idiopathic Pulmonary Fibrosis (IPF): an Italian real life study
Source: International Congress 2014 – IPF and surroundings
Year: 2014


Late Breaking Abstract - Long-term Effect of Pulmonary Rehabilitation under Nintedanib treatment in Idiopathic Pulmonary Fibrosis (FITNESS study)
Source: Virtual Congress 2021 – ALERT: Asthma in adult, in children and ILDs
Year: 2021



Predictive Findings of Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


Non - IPF Idiopathic Interstitial Pneumonia (IIPs)
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2019


Non - IPF Idiopathic Interstitial Pneumonia (IIPs)
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2018

Non - IPF Idiopathic Interstitial Pneumonia (IIPs)
Source: ERS Courses: Interstitial Lung Diseases
Year: 2019


Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019

Assessment of Treatment Response in Granulomatous Lymphocytic Interstitial Lung Disease (GLILD)
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019


The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic.
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020


Tracking crackles of Interstitial Lung Disease during sleep.
Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems
Year: 2018


Gender perspective in Interstitial Lung Diseases (ILD)
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019

Development Of A Machine Learning Combination With Deep Learning For Diagnosing Idiopathic Pulmonary Fibrosis In Chronic Interstitial Lung Disease
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


ATS / ERS: International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias
Source: Guideline 2002
Year: 2002

Late Breaking Abstract - First-in-Human Results of Bronchial Rheoplasty: An Endobronchial Treatment For Chronic Bronchitis (CB)
Source: International Congress 2018 – Interventional pulmonology highlights in 2018: latest innovations
Year: 2018



Role of Pulmonary Rehabilitation (PR) on clinical care in patients with advance Interstitial Lung Diseases. Does it make any difference?
Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care
Year: 2021


LATE-BREAKING ABSTRACT: Bosentan in Pulmonary Hypertension associated with Fibrotic Idiopathic Interstitial Pneumonia:A Randomized, Double-Blind, Placebo-controlled Study
Source: Annual Congress 2013 –Pulmonary circulation: treatment
Year: 2013